Fracture Risk Interventions in Osteoporosis
Effective interventions to reduce fracture risk in osteoporotic patients combine lifestyle strategies, pharmacological therapy, and fall prevention measures.
Importance of Reducing Fracture Risk
Osteoporosis weakens bone density and structure, increasing the likelihood of fractures even from minor trauma. In Australia, hip and vertebral fractures contribute significantly to disability, hospitalisation, and reduced quality of life in older adults. Preventing fractures is central to improving long-term outcomes and reducing healthcare costs.
Lifestyle and Nutritional Interventions
Adequate calcium and vitamin D intake are essential. GPs should recommend:
- Calcium: 1,000–1,300 mg daily from diet or supplements.
- Vitamin D: safe sun exposure or supplementation, especially in older adults or those with limited sun access.
Weight-bearing and resistance exercises improve bone density and strengthen muscles, reducing fall risk. Lifestyle advice should also include smoking cessation and limiting alcohol intake, as both increase bone loss.
Pharmacological Interventions
Patients at high risk of fracture benefit from medications that improve bone strength:
- Bisphosphonates (e.g., alendronate, risedronate) reduce vertebral and hip fracture risk.
- Denosumab is an option for patients intolerant to bisphosphonates, administered as a six-monthly injection.
- Selective oestrogen receptor modulators (SERMs) may be considered in postmenopausal women.
- Teriparatide and other anabolic therapies are reserved for severe cases.
GPs should review adherence, monitor side effects, and ensure regular bone mineral density (BMD) testing.
Fall Prevention Strategies
Because many fractures result from falls, reducing fall risk is critical. Interventions include:
- Home safety assessments and modifications.
- Balance and strength training through physiotherapy or community-based exercise programs.
- Medication reviews to minimise sedative use that increases falls.
- Vision and hearing checks, as impairments increase risk.
Monitoring and Follow-Up
AI-enabled recall systems can ensure regular BMD assessments, medication reviews, and fall risk reassessments. Automated reminders help patients stay on track with lifestyle, supplements, and follow-ups, improving long-term outcomes.
Compliance and Privacy
Managing osteoporosis involves sensitive health data and long-term monitoring. AI systems that track interventions embed encryption, role-based access, and audit trails, ensuring compliance with the Australian Privacy Principles (APPs) and RACGP standards.
Conclusion
Reducing fracture risk in osteoporosis requires a multifaceted approach—lifestyle optimisation, pharmacological therapy, and fall prevention. In Australia, these evidence-based strategies align with RACGP guidelines, ensuring safe, effective, and patient-centred care. Therefore, GPs can significantly reduce fracture rates and improve quality of life for patients through proactive management and consistent follow-up.